FDA launches first campaign against smokeless tobacco
This is the first time that the FDA has chosen to explain this angle of smokeless tobacco instead of focusing on smoke tobacco. The serious side effects of smokeless tobacco include gum disease, nicotine addiction, tooth loss and several varieties of cancer.
All of these negative effects are emphasized in the advertisements. The ads have been strategically installed in 35 different markets in the U.S. The goal is to reach the target audience of rural white males throughout the nation.
Smokeless tobacco comes in many forms, including chew, dip, snus and other kinds of tobacco that dissolve within a person’s mouth. Statistics form the Substance Abuse and Mental Health Services Administration show that approximately 1,000 males who are less than 18 years old use smokeless tobacco for the very first time each day. This figure is almost as high as the statistic for male teenagers smoking a cigarette for the first time.
“Not only is the target audience using smokeless tobacco at a high rate, but many do not fully understand the negative health consequences of their actions,” Mitch Zeller, director of the FDA’s Center for Tobacco Products, said. “In communities where smokeless tobacco use is part of the culture, reaching at-risk teens with compelling messaging is critical to help change their understanding of the risks and harms associated with smokeless tobacco use.”
Organizations in this story
U.S. Food and Drug Administration (FDA) 10903 New Hampshire Ave Silver Spring, MD 20903
Substance Abuse and Mental Health Services Administration 5600 Fishers Ln Rockville, MD 20852